A novel type of smart polymersomes with rapid K + -triggered drug-release properties is developed in this work. Block copolymers with biocompatible poly(ethylene glycol) (PEG) as the hydrophilic block and poly( N -isopropylacrylamide- co -benzo-18-crown-6-acrylamide) (PNB) copolymer as the K + -responsive block are successfully synthesized. Because of the presence of 18-crown-6 units, the PEG- b -PNB block copolymers exhibit excellent K + -dependent phase-transition behaviors, which show a hydrophilic–hydrophobic state in simulated extracellular fluid and present a hydrophilic–hydrophilic state in simulated intracellular fluid. Polymersomes with regular spherical shape and good monodispersity are prepared by the self-assembly of the PEG- b -PNB block copolymers. Both hydrophilic fluorescein isothiocyanate–dextran and hydrophobic doxorubicin are selected as model drugs and are successfully encapsulated into the PEG- b -PNB polymersomes. After being placed in a simulated intracellular fluid with high K + concentration, the PEG- b -PNB polymersomes immediately disassemble accompanied by the rapid and complete release of drugs. Such K + -responsive polymersomes with the desired drug-release properties provide a novel strategy for advanced intracellular drug delivery and release, which can enhance the safety and efficacy of cancer therapy.
No takes yet. Share an insight, caveat, or question.
You et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: